We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01983267
Recruitment Status : Completed
First Posted : November 13, 2013
Last Update Posted : May 8, 2017
Information provided by (Responsible Party):
Rambam Health Care Campus

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 26, 2017
  Study Completion Date : April 26, 2017